chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headache/horrendous headache; I couldn't do anything I was lying down the whole time; she reported she is now sneezing occasionally; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache/horrendous headache), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I couldn't do anything I was lying down the whole time) and SNEEZING (she reported she is now sneezing occasionally) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concomitant products included CALCIUM, VITAMIN C [ASCORBIC ACID] and COLECALCIFEROL (VITAMIN D3) for an unknown indication.    On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache/horrendous headache), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I couldn't do anything I was lying down the whole time) and SNEEZING (she reported she is now sneezing occasionally). At the time of the report, HEADACHE (headache/horrendous headache), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I couldn't do anything I was lying down the whole time) and SNEEZING (she reported she is now sneezing occasionally) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Information has been received from a physician's assistant concerning a child who was vaccinated with a dose of varicella virus vaccine live. On 09May05, the pt developed breakthrough chickenpox. Unspecified medical attention was sought. At the time of the report, the pt was recovering. A product quality complaint was not involved. Additional information has been requested.
Injection site pain, dismissing Free seal days, but still sore to touch on 1/30 ( nearly 2 weeks later) and a large rash present with some itchiness. Not sure how long that has been present, but noticed this morning 1/30.
23AUG95 sore arm; 24AUG this AM very tired, achy, flu like in upper body, felt very weak in shower & dizzy; arms numb & tingling; consulted family MD 24AUG;
pt recvd vax & exp crying in office slept off & on then started high pitched cry @ 1PM; kept getting APAP q 4 hrs; slept 2 mins @ a time high pitched scream all eve & noc;
Patient became very faint, light headed, sweaty and was breathing heavily within 5-10 minutes of vaccination. Patient was alert and oriented the whole time, but felt like her heart racing was getting worse and began feeling nauseous. Patient requested 911 be called. EMTs took patient to the hospital. Patient called to say she was treated, but did not know with what and she is now home and feeling fine.
After my 1st shot next day at work around 10am I start having headaches, bodyache, fever chil, client wife gave me 2 tylonol. Came home ninght time take more tylonol, next day fever is gone but my body have a lot of pain and numbness. Till today both arms , my head my legs the numbness still don?t go away
Real red and swelling around area. Then on 6/24/11 called Dr. office. It was itching real bad and real red and swollen around entire area of arm. Was told to put ice packs and take Benadryl.
3/17 8pm - found lethargic & vomiting taken to E.R.  3/17 11pm IV fluids & ZOFRAN discharged.  3/19 10pm starts petit mal seizures.  3/20 3am hospital admitted.  3/23 6pm Discharged.  Symptoms vomiting, anorexia, lethargy, inconsolably crying, petit mal seizures. 8/4/08-records received for DOS 3/20-3/23/08-DC DX: Acute gastroenteritis. Dehydration, improved. Metabolic acidosis, improved. Diet refusal for previous 24 hours, vomiting, diarrhea. Initial diagnosed with viral infection and treated with antibiotics. Crying inconsolable.
This spontaneous report as received from a registered nurse refers to a 04-month-old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 11-SEP-2017, the patient was vaccinated with improperly stored ROTATEQ (dosing details were not reported) (lot # M042170, expiry date: 22-JUN-2018) orally for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000054.
This 58 year old woman was admitted with covid pneumonia.  She was treated with remdesivir and steroids and is improved.  She is not hypoxic today and her lungs are clear.  She will complete steroids orally.   She did have symptoms of uti.  She will complete antibiotics orally.   She does have ckd.  Creatinine has been about 2.0.  We will arrange follow up with nephrology  outpatient
moderna vial was punctured more than 20 times/doses administered to patients after vial was puncture more than 20 times; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DISPENSING ERROR (moderna vial was punctured more than 20 times/doses administered to patients after vial was puncture more than 20 times) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Nov-2021, the patient experienced PRODUCT DISPENSING ERROR (moderna vial was punctured more than 20 times/doses administered to patients after vial was puncture more than 20 times). On 28-Nov-2021, PRODUCT DISPENSING ERROR (moderna vial was punctured more than 20 times/doses administered to patients after vial was puncture more than 20 times) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported by the reporter
soreness in her lymph node under her arm and 1-2 complained with sore lymph nodes similar to hers; they had a little bit of a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of LYMPH NODE PAIN (soreness in her lymph node under her arm and 1-2 complained with sore lymph nodes similar to hers) and PAIN IN EXTREMITY (they had a little bit of a sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPH NODE PAIN (soreness in her lymph node under her arm and 1-2 complained with sore lymph nodes similar to hers) and PAIN IN EXTREMITY (they had a little bit of a sore arm). At the time of the report, LYMPH NODE PAIN (soreness in her lymph node under her arm and 1-2 complained with sore lymph nodes similar to hers) and PAIN IN EXTREMITY (they had a little bit of a sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided. No concomitant medications were reported   Reporter did not allow further contact
Ataxia starting within 30 minutes of vaccine administration. Difficulty standing up unsteady gait, frequent falling down. Pt improving. Cough developed after vaccine.
This spontaneous report was received from a licensed practical nurse and refers to four patients of unknown age and gender. No information regarding the patients' pertinent medical history, concomitant medications and drug reactions or allergies was reported. On an unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ oral solution, lot # L038536, expiry date 19-AUG-2017. On an unknown date, the administered doses of ROTATEQ underwent temperature excursion at 1.2 Celsius degrees for 54 minutes. There was no previous temperature excursion. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reported received from the same reporter. Additional information has been requested.
Pt said about 10-13 days after she received the HD flu vaccine she had a small rash with some small blister on her right wrist,thumb nail on right hand, left thigh and left arm. Called to HD 11/7/2018 to report this and ask if it was related to the HD flu. She also reported working outside in the grass. Said she has been using hydrocortisone and calamine lotion for the itching. Enc pt to seek care of her PMD if needed.
Body aches, chills, fatigue, severe headache. All onset approximately 13 hours after vaccine.
Upon verification the nurse confirmed that the patient was informed by the employer that the flu vaccine administered to her was already expired and that is the reason why the patient consulted their facility with no reported adverse event; Initial information received on 07-Oct-2022 regarding an unsolicited valid  non-serious case received from a non-healthcare professional.  This case involves an unknown age female patient who was informed by the employer upon nurse confirmation, that Influenza Quadrival A-B Vaccine [Fluzone Quadrivalent] administered to her was already expired and that is the reason why the patient consulted their facility with no reported adverse event.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient was administered the expired Influenza Quadrival A-B Vaccine informed by the employer upon nurse confirmation and that is the reason why the patient consulted their facility with no reported adverse event (expired product administered) (route, form, strength, dose, expiry date and lot batch no) in an unknown administration site for immunization.  It was reported that 'Clinic manager called inquiring when they can give a patient her dose of FLUZONE QUADRIVALENT as the patient was given an expired FLUZONE QUADRIVALENT just a week ago from a different facility which is facilitated by the patient's employer'.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
simple febrile sz 12 hrs p/vax;no post-ictal complication;evaluated @ ER & released;tx w/antipyretics only
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 17-SEP-2013 the patient received an expired dose of ZOSTAVAX (lot number H011427, expiration date 12-SEP-2013) (dose and route were not reported). Concomitant medications were not provided. No adverse event reported. Additional information has been requested.
feel like someone punched my arm (same with the first dose); took aspirin-helped; a bit achy and tired (this started today 11/28/2020)
Had fever of 101 and chills for 3 days; severe headache; body ache; sore throat; weakness; nausea neuralgia in feet and legs for 2 days
pt recvd vax;reportedly as a result of the vax,pt contracted lupus & suffered serious bodily injury,both temporary & permanent; pt was hosp;this rpt has not been confirmed by hlth professional;
Aching, swollen feet followed by itching hives.  Hives on legs, ankles, feet, wrists, arms, torso, and buttocks.  Treated with Claritin and Benadryl; sought treatment through Nutrition Response Testing and am now taking whole food supplements.  Hives lasted for 2 weeks and now reappear periodically.
It began with Joint pain, headache, body aches, nausea, swollen lymphnodes/glands. Later that day, joints severely swollen. Knees swollen so badly, can't bend them, hands swell up intermittently. Headaches continue. The swelling goes down in about ten days. Flu like symptoms, body aches, mild fever, nausea continues for at least three weeks. My glands are still swollen, hands and knees swell up intermittently, still experiencing some headaches and nausea.
Headache, stiff neck, feels sick, treated w/ Tylenol and Ibuprofen.
Left Deltoid approx 14 hours after receiving TST/PPD and TDaP patient stated injection site was sore, warm and itchy but felt it was normal/expected. 24 hours after injection patient was complaining of increased pain, swelling and itchy systemically. Patient went to ED on 10/14/09 - BENADRYL.
On day 8 following vaccine, I noticed that the site of injection was red and raised.  It had not been up t then.  Red, raised area was about 2" x 3".  No pain, no other symptoms.  I massaged area in  a hot shower.  Also, had a headache in the middle of the night same date that was 5/10 pain and required 2 extra strength Tylenol-not normal for me.  I called my PCP.  She offered to see me, but did not require it. I chose not to be seen; I just wanted to make sure I wasn't overlooking something.
Notice lymph node swelling on left side on 1/7/20. Had vaccine 12/30/20. Just stopped sinus infection treatment on 1/7/21
hot like fire; chills; feels like I have the flu; ached; runny nose like a faucet; red; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (chills) and THROAT IRRITATION (scratchy throat) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and HYDROCHLOROTHIAZIDE (DIURETIC [HYDROCHLOROTHIAZIDE]) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced CHILLS (chills) and THROAT IRRITATION (scratchy throat). The patient was treated with IPRATROPIUM BROMIDE at an unspecified dose and frequency. At the time of the report, CHILLS (chills) and THROAT IRRITATION (scratchy throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient has given a pill by her pcp but she don't know the actual name of it.
This spontaneous report as received from a pharmacist refers to a 66 year old female patient with no drug reactions nor allergies. The patient's concurrent conditions included diabetes mellitus. On 10-NOV-2015, the patient was vaccinated with a dose of ZOSTAVAX lot # L024997, expiration date 06-OCT-2016, 0.65 ml, subcutaneously in left arm. Concomitant therapies included JANUVIA, glipizide and metformin. In November 2015 (reported as on or after 10-NOV-2015), the patient experienced redness and warmth in a radius of "about the size of a half-dollar" around the injection site on her left arm. The patient also developed an area of bruising "about two inches below" the injection site. The patient visited pharmacist. No lab diagnostics studies were performed and no treatment was given for the adverse events. The outcome of events was reported as not recovered. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Large erythema area 10 X 12 cm on left deltoid area, Tenderness developed 2 day after shot, with warmth, Pt given Keflex 500 mg po QID for cellulitis
Patient developed a fever about 6 days after receiving vaccines, fever got as high as 104 along with decreased appetite.
patient received an expired dose of the Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received an expired dose of the Moderna vaccine) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045J21A, 032B21A and 022C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received an expired dose of the Moderna vaccine). On 20-Dec-2021, EXPIRED PRODUCT ADMINISTERED (patient received an expired dose of the Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment details was reported.
Vaccine (MENACTRA) expired Oct 15, 2014. This report is only to report that expired vaccine was given.
8JUL92 t102 ax @ 930AM; t99ax-1030AM; t100.2Ax 230PM; t103Ax 4PM; t103A 6PM; t105AM 730PM; took APAP; when adverse reaction occurred to ER to cont w/Amoxycillin dx ear infect;
Numbness and tingling at my sides below the ribs and above the hips.  Numbness and tingling across my torso in a horizontal line.  I can feel the nerve as if it's an electric fence.  It's a solid wire.
Patient stated eyes were itchy and throat itchy. Stated she felt funny. Given 25mg oral Benadryl.  Resolution of symptoms before leaving vaccine site
Muscle pain, headache, chills, and fatigue. Started at 10am on Friday morning, lasted all through Friday, and by Saturday morning I felt back to normal.
mom called & stated pt was restless, has a tick in neck, shows little emotion, muscle twitching occurring 8 days p/inj;pt saw ER hosp 19FEB97;saw MD 21FEB97 w/dx of ?sz;
Patient descrived a metallic taste in her mouth 10 minutes after getting the COVID19 Vaccine. Soon after, she described the posterior left side of her tongue was feeling numb. No itching of throat, no swelling of lip or tongue. No respiratory or GI symtpoms. No urticaria or pruritis.  She was treated with loratadine 10 mg and famotidine 20 mg orally.  She was observed for 2 hours with no progression or additional symptoms. She was discharged to home.
Patient was mistakenly given ProQuad and Menactra together.  At this time she is not experiencing an adverse reaction.   Called to report and was advised to fill out this VAERS form.
everyone who got moderna really sick; Normal reaction; chills; fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (everyone who got moderna really sick), VACCINATION COMPLICATION (Normal reaction), CHILLS (chills), PYREXIA (fever) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (everyone who got moderna really sick), VACCINATION COMPLICATION (Normal reaction), CHILLS (chills), PYREXIA (fever) and HEADACHE (Headache). At the time of the report, ILLNESS (everyone who got moderna really sick), VACCINATION COMPLICATION (Normal reaction), CHILLS (chills), PYREXIA (fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported. No treatment medications were reported.
headache unrelieved by OTC ibuprofen 6/10 sore throat slight difficulty breathing (only happened this morning around 3 am) slight decline in hearing
Rt. thigh - area red, warm - area increased in size and developed a lg. red lump.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Mar-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of the patient was 37.66 years.  Concomitant products were not provided.  On 20-Mar-2021, Excursion time was 09 AM, temperature was 34, total doses given for the day was 184, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 9-Mar-2021, vial was moved to clinic on 20-Mar-2021. 19 vials were sent to clinic. Vaccine BUD date was 8-Apr-2021.  On 20-Mar-2021, vials were stored in cooler 1, at following time and temperature respectively,  9 AM: 34, 10 AM: 30, 11 AM: 41, 12 AM: 45, 1PM: 44, 2 PM: 44, 3 PM: 44, 4 PM: 44 and 5 PM: 43.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a  traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Arm was swollen to the elbow and had a hard knot. She said she was nauseated and dizzy and had a headache. She said she had no energy and couldn't get off the couch for 2 days.
Four days after the vaccination experienced severe dizziness.  Unable to walk or drive.  Diagnosed w BPPV in both ears.  Have been undergoing vestibular treatment for 6 months now.  Much better, but dizziness is not completely gone.
over course of 4 days immed following shots had temp 100;eyes rolled back in head & would shake head; each day wa a little less hrs;saw MD 4th day; MD said probably rxn to pertussis & Recommended half dose of pertussis in future;
Lips swollen and little bumps on back (not hives). Not itchy. No respiratory symptoms. No fever.
After vaccination administration, patient became lightheaded, and pale. I laid him down and held him under my arm, he began to shake his head slightly. I elevated his legs, and he then immediately got up and said he felt fine. Face turned back to original color, I asked him to stay for observation. After 20 minutes he left. Followed up with a call to parents and he has been doing well with no adverse reactions.